Submit efficacy data of Indian population: CDSCO Panel Tells Eli Lilly for approval of additional indications of Ixekizumab Dr. Divya Colin9 Oct 2024 6:00 PM ISTNew Delhi: Citing that there is no efficacy data in the Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Eli Lilly, RosVivo Therapeutics ink pact for diabetes treatment MD Bureau23 Feb 2022 2:20 PM ISTSeoul: RosVivo Therapeutics, Inc. has announced that the company has signed a Material Transfer Agreement (MTA) with Eli Lilly and Company for...
Antibody therapy may lower COVID hospitalizations: Eli Lilly Ruchika Sharma18 Sept 2020 12:32 PM ISTIndianapolis: Eli Lilly and Co on Wednesday said a single infusion of its experimental antibody treatment reduced the need for hospitalization and...
Eli Lilly diabetes drug Trulicity gets USFDA nod Ruchika Sharma6 Sept 2020 10:15 AM ISTThe additional doses of Trulicity will be available in US pharmacies in late September.
Higher doses of dulaglutide safe in reducing blood sugar, weight in diabetes Hina Zahid11 May 2020 12:45 PM ISTINDIANAPOLIS -Dulaglutide is a genetically engineered protein. It therefore has to be given by subcutaneous injection.Dulaglutide is once a week ...
Elanco finalises Novartis Animal Health India acquisition savita thakur thakur5 Jan 2016 9:53 AM ISTNew Delhi: Animal health products and knowledge services firm Elanco announced it had finalised its acquisition Novartis Animal Health India."Elanco's...
FDA approves Basaglar, the first follow-on insulin glargine product to treat diabetes savita thakur thakur17 Dec 2015 11:17 AM ISTThe U.S. Food and Drug Administration approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control...
USFDA approves Type 2 diabetes drug from Boehringer Ingelheim Pharmaceuticals and Eli Lilly Pooja Bhatia Bhatia28 Aug 2015 10:29 AM ISTUSFDA has approved a drug from Boehringer Ingelheim Pharmaceuticals (BIPI) and Eli Lilly and Company to help control blood glucose in people with Type...
